|
Apr 25
|
CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards?
|
|
Apr 24
|
Vertex Pharmaceuticals (VRTX) Advances But Underperforms Market: Key Facts
|
|
Apr 24
|
Top 20 biopharmas’ market cap rises 6% in Q1 2025 amid tariff headwinds
|
|
Apr 22
|
Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday
|
|
Apr 22
|
3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold
|
|
Apr 22
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
|
|
Apr 22
|
Fed Chairman Jerome Powell Warns Trump's Tariffs Could Cause Stagflation: 3 Stocks to Buy and Hold if He's Right
|
|
Apr 21
|
Vertex Pharmaceuticals (NasdaqGS:VRTX) Faces UK Patent Lawsuit Over Groundbreaking CASGEVY Therapy
|
|
Apr 15
|
Stock Market Whiplash: 3 Growth Stocks That Are No-Brainer Buys on the Bounce
|
|
Apr 14
|
April 2025's Stocks That May Be Priced Below Their Estimated Value
|
|
Apr 14
|
Exploring 3 High Growth Tech Stocks In The US Market
|
|
Apr 12
|
Nasdaq Market Whiplash: 3 Stocks to Buy Hand Over Fist and Hold for Decades
|
|
Apr 11
|
Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis
|
|
Apr 10
|
Vertex Pharmaceuticals (VRTX) Stock Moves -1.41%: What You Should Know
|
|
Apr 10
|
Vertex Pharmaceuticals (VRTX) Surged on Increased Demand for its Cystic Fibrosis (CF) Franchise
|
|
Apr 10
|
We're About to Find Out the Answer to Warren Buffett's Pointed Question About Trump's Tariffs. Here Are 3 Stocks to Buy Depending on What That Answer Is.
|
|
Apr 9
|
5 Top Growth Stocks to Buy in the Stock Market Sell-Off
|
|
Apr 7
|
2 Stocks to Buy if You're Worried About a Recession
|
|
Apr 7
|
Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4
|
|
Apr 6
|
Worried About Trump's New Tariffs? These 3 U.S. Companies Are Set to Weather the Storm
|